Neuspera Nuity System— 510(k) K221303

Name: FDA 510(k) clearance K221303
Creator: U.S. Food and Drug Administration
Published: 2023-04-11

Substantially Equivalent

Neuspera Medical, Inc.

FDA 510(k) clearance K221303 for Neuspera Nuity System, Substantially Equivalent on 2023-04-11. Applicant: Neuspera Medical, Inc.. Device class: 2.

Clearance details

Applicant: Neuspera Medical, Inc.
Product code: Code GZF
Device class: Class 2
Regulation: 21 CFR 882.5870
Advisory panel: Neurology
Date received: 2022-05-05
Decision date: 2023-04-11
Decision: Substantially Equivalent
Clearance type: Traditional
Location: San Jose, CA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code GZF

view all

K253877 — StimTrial Neuromodulation System2026-08-26
K243782 — StimTrial Neuromodulation System2025-07-16
K243678 — TalisMann Neuromodulation System2025-07-03
K232415 — Nalu Neurostimulation System for Peripheral Nerve Stimulation2024-08-21
K233162 — Freedom Peripheral Nerve Stimulator (PNS) System2024-06-20

More clearances from Neuspera Medical, Inc.

view all

K202781 — Neuspera Neurostimulation System (NNS)2021-08-27

Adverse events under product code GZF

product code GZF

Death: 10
Injury: 2,410
Other: 1
Total: 2,421

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.